$5.33
0.214.1%
Last update: Nov 6, 4:00 PM
NextCure Inc (NXTC) Stock Price, Quote, News & History
NXTCNASDAQ
NextCure will merge with Avere in a $320 million exchange to advance oral IL-23 therapy AVR-001 and list the combined company as AVRX.
You can purchase shares of NextCure (NASDAQ:NXTC) through any online brokerage.
Other companies in NextCure’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
NextCure has a consensus price target of $28.40.
The stock price for NextCure (NASDAQ: NXTC) is $5.69 last updated November 5, 2026 at 9:29 AM EST.
There are no upcoming dividends for NextCure.
NextCure does not have any upcoming earnings scheduled.
There is no upcoming split for NextCure.
NextCure is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
NextCure Inc is a clinical-stage biopharmaceutical company that is focused on advancing inventive medicines that treat cancer patients that do not respond to, or that have disease progression on, current therapies, through the use of targeted...
